共 275 条
[31]
Coelho L(2009)Midregional proadrenomedullin as a prognostic tool in community-acquired pneumonia Chest 136 823-54
[32]
Almeida E(2012)Copeptin predicts clinical deterioration and persistent instability in community-acquired pneumonia Respir Med 106 1320-9
[33]
Fernandes A(2010)Cardiovascular and inflammatory biomarkers to predict short- and long-term survival in community-acquired pneumonia: Results from the German Competence Network, CAPNETZ Am J Respir Crit Care Med 182 1426-72
[34]
Mealha R(2014)Diagnostic and prognostic power of biomarkers to improve the management of community acquired pneumonia in the emergency department Enferm Infecc Microbiol Clin 32 225-65
[35]
Moreira P(2012)Prognostic value of proadrenomedullin in severe sepsis and septic shock patients with community-acquired pneumonia Swiss Med Wkly 142 w13542-90
[36]
Sabino H(2014)Correlation of inflammatory and cardiovascular biomarkers with pneumonia severity scores Enferm Infecc Microbiol Clin 32 140-6
[37]
Menendez R(2011)C reactive protein, procalcitonin and proadrenomedullin in the outcome of hospitalized pneumonia patients Revista del Laboratorio Clinico 4 23-75
[38]
Martínez R(2012)Proadrenomedullin improves Risk of Early Admission to ICU score for predicting early severe community-acquired pneumonia Chest 142 1447-undefined
[39]
Reyes S(2005)Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay Clin Chem 51 1823-undefined
[40]
Mensa J(2007)Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults Clin Infect Dis 44 S27-undefined